Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation
PROJECT ABSTRACT
Pandemic preparedness requires strengthening surveillance for emerging viruses, but also a plan for public
health response when the next pathogen rapidly infects humans on a global scale. In order to ensure that the
disproportionate disability and death experienced among disadvantaged populations in the US does not repeat
in a future pandemic, public health agencies will need to validate resource allocation and surveillance tools
within a health disparities framework. The RADx-UP Consortium enables such as an evaluation, since this
NIH-funded Consortium of over 130 projects, with over 370,000 nationwide participants, focused on improving
test access, and eliciting COVID19 stress and vaccine perception among underserved persons. Using RADx-
UP data as the ground truth, we will test whether three area level vulnerability indices—the Social Vulnerability
Index, the Minority Health Social Vulnerability Index, and the Community Vulnerability Index—identify persons
experiencing food or housing insecurity, or gaps in healthcare access during the pandemic (Aim 1). We will
leverage methods from clinical trial literature to assess RADx-UP data generalizability. We will link to American
Community Survey, and generate county-standardized estimates of pandemic stress and vaccine concerns for
the more than 900 US counties with participants in the RADx-UP consortium. We will then assess the
association of these standardized estimates with the three area level vulnerability indices. A second aim of the
proposed work will be to assess the predictive performance of the promising tool of wastewater surveillance
among underserved populations. We will link RADx-UP data with the publicly available National Wastewater
Surveillance System data, and compare wastewater infection prevalence metrics with the test positivity rate
among RADx-UP performed tests, and county-level hospitalizations and deaths. We will evaluate changes in
predictive performance over time (e.g., before versus after vaccine availability), and with integration of area-
level vulnerability indices and other census demographic variables. With the ultimate aim of reducing health
disparities in the future pandemic, our team of epidemiologists, statisticians, nephrology and infectious disease
clinicians, and health policy experts will evaluate existing and emerging pandemic preparedness tools. In doing
so, we hope to promote a public health infrastructure responsive to groups most vulnerable to the health and
social turbulence inherent to a pandemic.
Public Health Relevance Statement
PROJECT NARRATIVE
The Rapid Acceleration in Diagnostics for Underserved Population (RADx-UP) consortium
recruited over 370,000 participants to generate data on COVID-19 testing, pandemic stress, and
vaccination among underserved and vulnerable persons across the US. Our team of
epidemiologists, and chronic disease, infectious disease, and health policy experts plans to use
these data test the performance of public health resource allocation and infection surveillance
tools. Our goal is to mitigate health disparities during the inevitable future pandemic.
NIH Spending Category
No NIH Spending Category available.
Project Terms
2019-nCoVAgeAmericanAmerican IndiansAreaBlack raceCOVID-19 incidenceCOVID-19 pandemicCOVID-19 stressCOVID-19 testCOVID-19 testingCOVID-19 vaccineCensusesCenters for Disease Control and Prevention (U.S.)Cessation of lifeChronic DiseaseClassificationClinical TrialsCommunicable DiseasesCommunitiesCommunity SurveysCountyDataDialysis procedureDiseaseDisease OutbreaksDisparity populationEbolaEmploymentEpidemiologistEthnic OriginEvaluationFaceFoodFundingFutureGoalsHealthHealth InsuranceHealth PolicyHealth systemHispanicHospitalizationHouseholdHousingHumanIncomeInfectionInfluenzaInfluenza A Virus, H1N1 SubtypeInfrastructureInvestmentsLinkLiteratureLocationMethodsMiddle East Respiratory SyndromeMonkeypoxNeighborhoodsNephrologyOutcomeParticipantPatientsPerceptionPerformancePersonsPhasePopulationPositive Test ResultPragmatic clinical trialPrevalencePublic HealthPublic Health PracticeRADx Underserved PopulationsRaceReduce health disparitiesResource AllocationResourcesSamplingSevere Acute Respiratory SyndromeSeverity of illnessSiteSpeedStandardizationStressSystemTest ResultTestingTimeTractionTriageUncertaintyUnderserved PopulationUnited States National Institutes of HealthVaccinationVaccinesVulnerable PopulationsWorkZIKAdata structuredisabilityemerging virusevidence baseexperiencefuture pandemichealth care availabilityhealth disparityhome testhospitalization ratesimprovedimproved outcomeindexingmedical vulnerabilityminority healthmortalitynew pandemicoperationpandemic diseasepandemic preparednesspandemic stresspathogenperformance testspopulation surveypredictive testpublic health emergencyrecruitresponsescreeningsecondary analysissexsocialsocial vulnerabilitysocioeconomicsstressortesting accesstesting uptaketooluptakevaccine accessvulnerable communitywastewater surveillance
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
009214214
UEI
HJD6G4D6TJY5
Project Start Date
21-September-2023
Project End Date
30-June-2025
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$193,000
Direct Costs
$125,000
Indirect Costs
$68,000
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Minority Health and Health Disparities
$193,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21MD019394-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21MD019394-02
Patents
No Patents information available for 5R21MD019394-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21MD019394-02
Clinical Studies
No Clinical Studies information available for 5R21MD019394-02
News and More
Related News Releases
No news release information available for 5R21MD019394-02
History
No Historical information available for 5R21MD019394-02
Similar Projects
No Similar Projects information available for 5R21MD019394-02